Term Name: EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
Synonyms: EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitors, EC 1.8.1.12 inhibitor, EC 1.8.1.12 inhibitors, N(1),N(8)-bis(glutathionyl)spermidine reductase inhibitor, N(1),N(8)-bis(glutathionyl)spermidine reductase inhibitors, NADPH2:trypanothione oxidoreductase inhibitor, NADPH2:trypanothione oxidoreductase inhibitors, NADPH:trypanothione oxidoreductase inhibitor, NADPH:trypanothione oxidoreductase inhibitors, trypanothione reductase inhibitor, trypanothione reductase inhibitors, trypanothione-disulfide reductase (EC 1.8.1.12) inhibitor, trypanothione-disulfide reductase (EC 1.8.1.12) inhibitors, trypanothione:NADP(+) oxidoreductase inhibitor, trypanothione:NADP(+) oxidoreductase inhibitors
Definition: An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of trypanothione-disulfide reductase (EC 1.8.1.12).
Ontology: ChEBI [CHEBI:77402]  ( EBI )

Relationships
is a type of: EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor) inhibitor
has subtype: EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor
inverse has_role: citalopram clomipramine ebselen quinacrine thioridazine trifluoperazine